MERTK and metabolic dysfunction-associated steatohepatitis: Starting from this evidence, we investigated whether the MERTK variant A>G can influence the risk of progression of liver disease, in patients with chronic infection sustained by hepatitis viruses (C or B) or with nonalcoholic steatohepatitis (NASH).